India's Injection Weight-Loss Trend | DW News

Why It Matters

The trend raises public-health concerns as off-label cosmetic use of potent diabetes drugs spreads rapidly, risking adverse effects and straining regulatory oversight, while reflecting deeper social pressures that drive medicalized beauty solutions. Policymakers, healthcare providers and consumer-safety regulators may need to act to curb unsafe use and address cultural drivers.

Summary

A growing number of women in urban India are using diabetes-derived weight-loss injections such as Mounjaro and Ozempic to slim down ahead of weddings, driven by intense social and bridal beauty pressures. The trend is fueled by cheap, easily accessible doses priced as low as €20 and by awareness of aesthetic procedures like injection lipolysis for problem areas. Medical experts warn of side effects including nausea, vomiting, diarrhea and reports of acute pancreatitis, while critics highlight underlying body-image and societal expectations. Users and providers frame the injections as a practical shortcut to meet cultural demands for brides to appear slim and conventionally attractive.

Original Description

As wedding pressure builds in urban India, more brides are turning to weight-loss injections to achieve the "perfect look." But behind the trend are questions about health risks, beauty standards, and growing social pressure. #dwasia

For more news go to: http://www.dw.com/en/

Follow DW on social media:

►Instagram: https://www.instagram.com/dwnews

►TikTok: https://www.tiktok.com/@dwnews

►Facebook: https://www.facebook.com/deutschewellenews/

►Twitter: https://twitter.com/dwnews

Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/dwdeutsch

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

#Ozempic #Weightloss #Lipolysis